MARKET

ADXS

ADXS

Advaxis
NASDAQ

Real-time Quotes | Nasdaq Last Sale

0.2935
-0.0055
-1.84%
After Hours: 0.3000 +0.0065 +2.21% 19:28 09/20 EDT
OPEN
0.2900
PREV CLOSE
0.2990
HIGH
0.3090
LOW
0.2825
VOLUME
7.22M
TURNOVER
--
52 WEEK HIGH
14.55
52 WEEK LOW
0.2600
MARKET CAP
7.25M
P/E (TTM)
-0.0680
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of ADXS and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 2 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

ADXS News

  • 18 Healthcare Stocks Moving In Thursday's Pre-Market Session
  • Benzinga.3d ago
  • Is This A Catalyst To Buy Advaxis, Inc. (NASDAQ:ADXS)?
  • Simply Wall St..3d ago
  • 22 Healthcare Stocks Moving In Monday's Pre-Market Session
  • Benzinga.6d ago
  • The Daily Biotech Pulse: Translate Bio Halts mRNA Therapy Trial, Roche Multiple Sclerosis Biomarker Data, D-Day For Xeris
  • Benzinga.09/10 12:36

More

Industry

Biotechnology & Medical Research
+0.62%
Pharmaceuticals & Medical Research
+0.95%

Hot Stocks

Name
Price
%Change

About ADXS

Advaxis, Inc. is a clinical-stage biotechnology company focused on the discovery, development and commercialization of Listeria monocytogenes (Lm)-Listeriolysin O (LLO) cancer immunotherapies. These immunotherapies are based on a platform technology that utilizes live attenuated Lm bioengineered to secrete antigen/adjuvant fusion proteins. These Lm-LLO strains integrate multiple functions into a single immunotherapy as they access and direct antigen presenting cells to stimulate anti-tumor T-cell immunity, stimulate and activate the immune system with the equivalent of multiple adjuvants, and simultaneously reduce tumor protection in the tumor microenvironment to enable the T-cells to eliminate tumors. Axalimogene filolisbac is its lead Lm-LLO immunotherapy product candidate for the treatment of Human Papilloma Virus-associated cancers. ADXS-PSA is its Lm-LLO immunotherapy product candidate that targets the Prostate Specific Antigen (PSA) associated with prostate cancer.
More

Webull offers Advaxis, Inc. (ADXS) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.